Target Validation Information
TTD ID	T58238
Target Name	Activation B7-1 antigen (CD80)
Type of Target	Successful
Drug Potency against Target	Abatacept	Drug Info	Kd = 8.7 nM	[1]
References
REF 1	Differential effects of CTLA-4 substitutions on the binding of human CD80 (B7-1) and CD86 (B7-2). J Immunol. 1996 Feb 1;156(3):1047-54.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.